Taiwan Biosim Company’s product catalog

Ogivri 150mg / 440 mg

ingredients：Trastuzumab

Ogivri is used for early breast cancer, metastatic breast cancer, and metastatic gastric cancer with HER2 overexpression or HER2 gene amplification.

package insert 150mg

package insert 440mg

Fulphila

ingredients：Pegfilgrastim

Used to decrease the incidence of infection, as manifested by febrile neutropenia, in patients with non-myeloid malignancies receiving myelosuppressive anti-cancer drugs associated with a clinically significant incidence of febrile neutropenia

package insert

Hulio Solution

ingredients：Adalimumab

Rheumatoid joints, psoriatic arthritis, ankylosing spondylitis, Crohn"s disease, psoriasis, ulcerative colitis, intestinal Bessie"s disease, hidradenitis suppurativa, uveitis.

package insert

ABEVMY

ingredients：Bevacizumab

Indicated for metastatic colorectal cancer (mCRC), metastatic breast cancer (mBC), malignant glioma (WHO grade 4) - glial cell tumor, advanced, metastatic or recurrent non-squamous non-small cell carcinoma NSCLC, epithelial ovarian cancer, fallopian tube or primary peritoneal cancer, persistent, recurrent, or metastatic cervical cancer.

package insert

Nepexto Solution

ingredients：Etanercept

Indicated for adults with active rheumatoid arthritis who have not responded adequately to disease-modifying anti-rheumatic drugs (DMARDs, such as methotrexate). It can be used in combination with Methotrexate to treat patients who do not respond adequately to Methotrexate alone. It is also indicated for active polyarticular juvenile chronic arthritis in children aged 4 to 17 years who have failed or cannot tolerate methotrexate treatment.

package insert

Semglee Solution

ingredients：Insulin glargine

This medicine is a long-acting insulin produced by using recombinant DNA technology. It is an insulin analogue and is used to treat hyperglycemia in diabetic patients over 6 years old.

package insert